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Membrane potentialOxidative redox titrations of the mitochondrial cytochromes were performed in near-anoxic RAW 264.7 cells
by inhibiting complex I. Cytochrome oxidation changes were measured with multi-wavelength spectroscopy
and the ambient redox potential was calculated from the oxidation state of endogenous cytochrome c. Two
spectral components were separated in the α-band range of cytochrome oxidase and they were identiﬁed as
the difference spectrum of heme a when it has a high (aH) or low (aL) midpoint potential (Em) by comparing
their occupancy during redox titrations carried out when the membrane potential (ΔΨ) was dissipated with a
protonophore to that predicted by the neoclassical model of redox cooperativity. The difference spectrum of
aL has a maximum at 605 nmwhereas the spectrum of aH has a maximum at 602 nm. The ΔΨ-dependent shift
in the Em of aH was too great to be accounted for by electron transfer from cytochrome c to heme a against ΔΨ
but was consistent with a model in which aH is formed after proton uptake against ΔΨ suggesting that the
spectral changes are the result of protonation. A stochastic simulation was implemented to model oxidation
states, proton uptake and Em changes during redox titrations. The redox anti-cooperativity between heme a
and heme a3, and proton binding, could be simulated with a model where the pump proton interacted with
heme a and the substrate proton interacted with heme a3 with anti-cooperativity between proton binding
sites, but not with a single proton binding site coupled to both hemes.eme a; aL, low potential or
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Cytochrome oxidase (CytOx) is the terminal oxidase of the
mitochondrial electron transport chain and is responsible for ≈90%
of cellular oxygen consumption (recently reviewed in [1]). The X-ray
structure has conﬁrmed that electrons from cytochrome c (Cytc) enter
the enzyme at the CuA site which is located on the intermembrane
side of the enzyme [2,3]. The electrons are transferred to the heme a
center, which is located ≈1/3 into the inner membrane, and then
parallel to the membrane to the binuclear center composed of heme
a3 and CuBwhere oxygen is reduced towater in a concerted 4-electron
reduction. Part of the energy released on reduction of oxygen by Cytc
is conserved by pumping 4 protons per oxygen from the matrix to the
intermembrane space against a proton motive force (ΔP). In many
models, proton pumping is achieved by coupling the pKa of a putative
pumping site to themidpoint potential (Em) of heme a and/or heme a3
[4] although a model has been proposed in which the pKa of the pump
site is coupled to the pKa of a second site via a conformational change
in the protein [5]. A current focus of research is on elucidating the
proton pathways and the mechanism of proton pumping [5–7].However, a complete description of CytOx function must also include
how CytOx dynamically varies its turnover rate depending on the
energization of the inner membrane [8,9], how the apparent oxygen
afﬁnity for turnover is decreased in the functioning enzyme compared
to the isolated enzyme[10] as well as how respiratory control is
altered by the possible phosphorylation of CytOx under control of
signaling pathways [11]. Such a description requires a detailed
knowledge of the properties of the redox centers and their
relationship to the membrane potential (ΔΨ) and pH gradient across
the inner membrane.
The early classical model postulated that heme a and heme a3 were
independent redox centers and that their spectral contributions to the
Soret bandwere approximately equalwhereas hemeadominated in the
α-band [12]. Later work performing redox titrations using the α-band
region in the absence [13] and presence [14] of ΔP found two n=1
redox transitions each with a distinct spectral signature which were
assigned to hemea andhemea3. In order to account for spectral changes
on ligand binding, the authors concluded that there were considerable
spectral interactionsbetweenhemea andhemea3 in theα-band region.
Later work, which took into account the results of redox titrations using
EPR spectroscopy and optical spectroscopy of the Soret- and α-band
features, concluded that heme a3 makes little contribution to the
absorption spectrum in the α-band region and that the non-Nernst
relationship observed in α-band redox titrations was the result of anti-
cooperative redox interactions between the heme a and heme a3 [15].
This culminated in the neoclassical model in which the spectral
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heme a3 have a high Em when the other center is oxidized (typically
360 mV) and a low Em when the other center is reduced (typically
240 mV) [16]. Redox titrations performed with Raman spectroscopy
[17], magnetic circular dichroism [18] and infrared spectroscopy [19],
where multiple redox centers can be followed, have shown and
conﬁrmed the redox anti-cooperativity between heme a and heme a3
but the origin of the spectral changes in theα-band region of CytOx has
not been determined. Attempts have been made to extend the
neoclassical model to include CuB [20,21] and CuA [21,22].
Electrostatic calculations have suggested that the anti-cooperativity
can be explained in terms of simple electrostatic repulsion between
the hemes [23]. However, these calculations do not take into account
the uptake of protons which would tend to shield the charge on the
hemes. Alternatively, a recent kinetic study in which electron transfer
and proton transfer were followed in real time has introduced the
concept that the midpoint potentials of heme a, heme a3 and CuB are
dependent on protonation events [24]. Electrons were injected into
the CuA center with nanosecond temporal precision and four phases
of electron and proton movements were observed. The ﬁrst phase
(τ=10 μs) involves electron equilibration between CuA and heme a
inwhich heme a and heme a3 havemidpoint potentials of 270 mV and
b130 mV. The second phase (τ=150 μs) involves uptake of the
pumpedproton to a site estimated to be above the hemeswhich raises
the Emof heme a and heme a3 to+360 mVand results in equilibration
of the electron between the three centers. During the ﬁrst two phases,
CuB acts with a midpoint of b130 mV but the substrate proton uptake
in the third phase (τ=800 μs) raises the Em of CuB to N460 mV and
results in complete transfer of the electron to CuB. The ﬁnal phase
(τ=2400 μs) involves release of the pumped proton into the p-side of
the membrane.
Recently, we have developed an optical spectroscopy system that
can measure oxidation changes of the cytochromes of the bc1
complex, Cytc and CytOx from the change in attenuation spectrum
of living cells in suspension [25]. The advantage of performing these
measurements in cells rather than isolated mitochondria is that the
mitochondria in living cells are operating under genuine physiological
conditions. Our overall goal is to develop and validate a kinetic model
of CytOx that can account for changes in the apparent oxygen afﬁnity
for turnover, the dependence of turnover on ΔΨ, pH gradient and Cytc
redox potential and how this dependence can be altered under the
control of cell signaling pathways. Such a model can only be validated
in a system in which CytOx pumps against a physiological membrane
potential. Furthermore, a cell model is essential to examine the effects
of cytosolic signaling pathways onmitochondrial function. The goal of
the studies presented here is to quantify and interpret the spectral
changes that occur in the α-band range of CytOx and to reconcile the
neoclassical model with proton–electron interactions revealed from
the more recent kinetic studies.
In this work, carried out on RAW 264.7 mouse macrophage cells, it
is shown that there are two distinct but overlapping spectral
components in the α-band range of CytOx. These components
are separated into the familiar 605 nm band of heme a which we
label aL and a previously unassigned 602 nm band which we label aH.
Within the framework of the neoclassical model, we show that the aL
and aH components can be assigned to the difference spectrum of
heme a when it has a low or high midpoint potential, respectively.
Furthermore, we show that the shift in the Em of aH on de-
energization of the inner membrane is too great to be accounted for
by themovement of an electron from Cytc to heme a against ΔΨ but is
consistent with a model in which aH is formed after proton uptake
against ΔΨ. Finally, we implement a stochastic simulation of CytOx
reduction using the reaction constants determined from the kinetic
study and show that it results in strong redox cooperativity between
heme a and heme a3 rather than anti-cooperativity and that it cannot
account for the spectral changes observed during redox titrations if aHis formed on binding of the pump proton. In contrast, a model in
which (1) the pump proton interacts with heme a to raise its Em
forming aH and (2) the substrate proton interacts with heme a3 to
raise its Em reproduces both redox anti-cooperativity and the spectral
changes if there is strong anti-cooperativity between the proton
binding sites.
2. Experimental procedures
2.1. Cell culture and measurement chamber
RAW 264.7 mouse macrophage cells were cultured at 37 °C in
250 mL spinner ﬂasks in phenol red-free RPMI mediumwith 10% fetal
bovine serum and antibiotics/antimycotics in a 95% air / 5% CO2
humidiﬁed incubator. Cells were spun down at 500 g for 5 min and
resuspended at a concentration of 2.0×107 cells per mL in RPMI
medium in a stirred 6 mL custom-built chamber that consisted of a
quartz cylinder of inside diameter of 17 mm surrounded by water
jacket to maintain the cells at 37 °C. The oxygen concentration was
measured from the ﬂuorescence lifetime of phosphorescent mem-
brane (Tautheta Instruments, Boulder, CO) located at the bottom of
the chamber.
The chamber was sealed with a stainless steel plunger and oxygen
consumption measured from the depletion of oxygen (respirometry
mode) or oxygenated and deoxygenated under computer control by
passing a gas mixture of 5% CO2 and a blend of N2 and O2 through
90 mm of ﬁne-bore silicone tubing immersed in the cell suspension
(oximetry mode). The tubing delivered oxygen to the suspension
medium at a rate proportional to the difference in oxygen tension
between inside the tubing and in the medium. Typically, the cells
required an oxygen fraction of 0.40 in the tubing to match oxygen
delivery to cellular consumption at an oxygen concentration of
100 μM.
2.2. Spectroscopy
The cells were illuminated with a white light emitting diode
(NFSW036B, Nichia, Detroit, MI) and light was collected with 1 mm
optical in remission geometry with a source-detector separation of
10 mm. The differential pathlength was measured using the 2nd
differential technique from the 740 nm absorption band of water [26]
and was found to be ≈39 mm. The output of the ﬁber was focused
onto the slits of a Triax 320 spectrograph (HORIBA Jobin Yvon, Edison,
NJ) and complete spectra were collected between 508 and 640 nm on
a CCD (DV401BV, Andor Technology, South Windsor, CT). The pixel
bandpass was≈0.13 nm and the entrance slit width was set to give a
spectral resolution of 1 nm.
2.3. Spectral analysis
The cytochrome oxidation changes were calculated by ﬁtting a
linear combination of model spectra to the change in attenuation
spectrum. Themodel spectra were bH, bL and c1, from the bc1 complex,
Cytc, and aL, aH and a3 from CytOx as well as a quadratic background to
account for any baseline drift. Attenuation spectra are presented with
the background subtracted but without smoothing. The difference
spectra of heme a3 and the familiar 605 nm form of heme a (aL) were
collected by Lao and Palmer [27] from the isolated bovine enzyme.
It was found that the anoxic-oxygenated difference spectra of the
cells showed heme a predominately as aH and could not be ﬁtted as a
combination of heme a and heme a3 spectra [27] whereas CytOx
became fully reduced after addition of FCCP under anoxic conditions
(see Fig. 3). As heme a can be expected to be almost fully reduced
under both anoxic conditions, the change in attenuation contains a
component of the spectrum of aL+a3–aH scaled by an arbitrary factor
as well as small components due to oxidation changes in the other
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average change in attenuation spectrum of six independent experi-
ments by ﬁrst ﬁtting a pair of Gaussians to the major feature at
609 nm between 590–630 nm. This spectrum, the other hemes and a
quartic background spectrum was then ﬁtted to the average
attenuation spectrum and the spectrum of aL+a3–aH was assumed
to be the sum of Gaussians and the quartic background. The rationale
for this procedure is that the hemes have sharp spectral features
whereas the quartic background can account for the slowly varying
features of aL+a3–aH in the range 510–590 nm. Once the spectral
shape of aL+a3–aH was extracted from the attenuation spectrum, it
was scaled by performing a non-linear least squares ﬁt to the
neoclassical model using the scaling factor as a fourth parameter
and the spectrum of aH calculated.
2.4. Stochastic simulations
A stochastic model based on Gillespie's algorithm [28] following
Ransac et al. [29] but including interactions between states was
implemented in Delphi 2010 using mixed object Pascal and assembly
language. In brief, CytOx was modeled containing Cytc binding site,
four redox centers (CuA, heme a, heme a3 and CuB) and either two or
three protonation centers. The electrostatic or conformational
interaction between reduced redox centers and protons were
included by changing the forward and reverse rate constants when
the interacting centers were both reduced and protonated. The
models do not include electron–electron interactions between the
redox centers as the goals were to show that proton–electron
interactions can lead to the heme centers titrating as if electron–
electron interactions were present. Great care was taken to ensure the
energy of a state was independent of the reaction pathway by which
that state was reached, that is, the models are thermodynamically
consistent.
Twomodelswere considered.Model I uses theparameters of a recent
kinetic study in which the O to E reactionwas followed in real time [24].
This model includes two proton binding sites, a pump site in which the
proton interacts with heme a and heme a3 and a substrate site in which
the proton interacts with CuB. Model II uses the same parameters as
model I except that the pump proton only interacts with heme a and a
second substrate site is included which interacts with heme a3.
Electrostatic interactions are long ranged compared to the separation
of the heme centers and only having the pump proton interact with
heme a and the substrate protons interactwith thebinuclear center is an
approximation but it allows the model to be as simple as possible. An
additional reaction is included to allow the substrate proton to move
rapidly between substrate sites. The energy levels and equilibration rates
(deﬁned as the sumof the forward and reverse rate) evaluated at a pHof
7.0, a Cytc redox potential of 0 mV and setting the energy of the fully
oxidized enzyme to 0 mV for the two models are summarized in Fig. 1.
Fig. 1A shows docking of Cytc, transfer of the electron to CuA and then
hemea anduptake of thepumpproton. These transitionsare common to
bothmodels. Fig. 1B shows transfer of the electron fromheme a to heme
a3, and then CuB with uptake of the substrate proton and release of the
pump proton for model I. Fig. 1C shows the equivalent for model II
consisting of electron transfer to heme a3, uptake of the ﬁrst substrate
proton and release of the pump proton followed by transfer of the
electron and substrate proton to CuB. The states in gray show energy
levelswithout the proton–electron interactions. The interactions in both
models are−210 mV for heme a,−350mV for heme a3 and−570 mV
for CuB.
The temporal evolution of the enzyme on photo-induced reduction
of CuA was simulated by initializing the model with the CuA center
reduced, the Cytc binding center empty, the other redox centers
oxidized and the proton sites empty. The enzyme was allowed to
evolve stochastically (excluding the Cytc binding reactions) and the
occupancy of each state was logged at 1 μs intervals for 10 ms ofenzyme turnover. Charge transfer was calculated from the time-
integral of electron transfer from CuA to heme a reaction and proton
transfer reactions assuming the binuclear center and the pump site
are located 34% and 25% from the cytosolic side of the membrane,
respectively. An ensemble of enzymes was modeled by averaging the
occupancy of each state at each time point over 10,000 separate
simulations. Computational time was approximately 18 s on a six-
core 3.2 GHz AMD Phenom II processor.
Redox titrations were simulated by allowing a single CytOx to
interact with a thermodynamic pool of Cytc. This was achieved by
scaling the forward rate for reduced and oxidized Cytc binding by the
fraction that Cytc would be reduced (fr) or oxidized (fo), respectively,
at a given redox potential of the Cytc pool. This is equivalent to
varying the concentration of reduced and oxidized Cytc appropriate to
the redox potential of Cytc assuming a ﬁrst order forward reaction.
The model was initialized with the Cytc binding site empty, the redox
centers oxidized and the proton binding sites empty. The enzyme was
allowed to evolve stochastically for 108 partial reactions (a minimum
of 80 s of enzyme turnover) and the time-weighted average
occupancy of each state logged. Computational time was approxi-
mately 38 min for 55 redox potentials on a six-core 3.2 GHz AMD
Phenom II processor. In both sets of simulations, aH and aL were
deﬁned as the states in which heme awas reduced and the pump site
was protonated or unprotonated, respectively.
3. Results
3.1. Spectra
Cells were placed in the sealed chamber and allowed to consume
the oxygen until they became anoxic whereupon 1 μM FCCP, a proton
ionophore, was added to collapse ΔP. Fig. 2A shows the change in
attenuation spectra between saturating oxygen concentration and
anoxia before and after the addition of FCCP. Prior to addition of
FCCP, the attenuation spectra showed a peak at 550 nm corresponding
to the α-band of Cytc, a shoulder at ≈560 nm corresponding to the
α-band of the b-cytochromes from the bc1 complex, a peak at≈521 nm
corresponding to the overlapping β-bands of Cytc, c1, bH and bL, and a
peak at 602.4 nm in theα-band region of CytOx. Theα-band of heme c1
was not resolved from the more intense α-band of Cytc. After FCCP,
therewere small changes at≈536 nmand≈560 nmand theα-band of
CytOx increased in magnitude and shifted to 605 nm. The change in
attenuation spectrum between saturating oxygen and anoxia prior to
FCCP was poorly ﬁtted by the spectra of heme aL and heme a3 as
indicated by the residuals of the ﬁt, whereas a good ﬁt was found after
addition of FCCP (see Fig. 2B).
The difference attenuation spectrum on addition of FCCP is shown
in Fig. 2C. The difference spectrum is dominated by a band centered at
≈609 nm. The changes at 560 nm are resolved into a double peak
which is characteristic of an oxidation of heme bL. The component of
the attenuation spectrum that the ﬁtting algorithm attributes to heme
bL is overlaid. This component, along with much smaller components
attributed to heme bH, heme c1 and Cytc, was subsequently subtracted
to give the difference spectrum of the fully reduced enzyme and aH.
The difference spectrum, which was calculated from the average of six
difference spectra from independent experiments and scaled as
described in the methods section, was subtracted from the spectrum
of the fully reduced enzyme to give the spectrum of aH. The spectrum
of aH is compared to the difference spectra of heme a (assumed to be
aL) and heme a3, both measured from the bovine enzyme [27], in
Fig. 2D. The spectra of aH and aL have peaks at 602.1 and 605 nm,
respectively, and have the same 630 nm-peak intensity to within 3%.
Fig. 3 shows temporal traces of cytochrome oxidation changes
when the heme aH and aL spectra were included in the decomposition
algorithm. The cells consumed oxygen in the chamber until anoxia at
0 min and then 1 μM of FCCP was added at 2 min. At high oxygen
Fig. 1. The energy levels and equilibration rates (deﬁned as the sum of the forward and reverse rate) evaluated at a pH of 7.0 and a Cytc redox potential of 0 mV for the two stochastic
models. The states are described in the key where the Cytc binding site can either be empty (E), bound with reduced Cytc (R) or bound with oxidized Cytc (O); CuA, heme a, heme a3
and CuB can either be oxidized (O) or reduced (R) and the proton sites can either be empty (E) or protonated (H). The energy of states without electron–proton interactions are
shown in gray. (A) Docking of Cytc, transfer of the electron to CuA and then heme a and uptake of the pump proton. These states are common to both models. (B) Transfer of the
electron from heme a to heme a3 and then CuB with uptake of a substrate proton and ejection of the pump proton for model I. (C) Transfer of the electron from heme a to heme a3,
uptake of the substrate proton, ejection of the pump proton and the transfer of the electron and substrate proton to CuB for model II.
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oxidation state was independent of oxygen concentration. As the cells
became anoxic, hemes bH, bL, c1 and Cytc became reduced as would be
expected. Addition of FCCP led to transient oxidations in heme bH,
heme c1 and Cytc which can be attributed to the small quantity of
oxygen that is dissolved in the FCCP solution and that was
subsequently consumed. This is borne out in the oxygen trace
which shows a transient increase of≈0.2 μM. However, FCCP caused
a substantial and sustained oxidation in heme bL consistent with the
collapse in ΔΨ causing an oxidation of heme bL with respect to heme
bH.
Oxidation changes in heme a (described as aT in the ﬁgures) were
calculated from the sum of oxidation changes in aH and aL. Heme a
reduced on anoxia as expected but, within the framework of the
neoclassical model, heme a3 remained partially oxidized as deter-
mined by the high occupancy of aH. This is borne out by the heme a3
trace, although the heme a3 trace has a lower signal to noise and is
more susceptible to drift because its spectrum is weaker and broader
than the other hemes. On addition of FCCP, heme a remained fully
reduced and heme a3 also became reduced as indicated by the switch
from aH to aL and a reduction in heme a3.
3.2. Redox titrations
Oxidative redox titrations were performed in the cells without
addition of exogenous redox mediators by inhibiting entry of
electrons into the electron transport chain at complex I with a low
concentration of rotenone in the presence of a low concentration ofoxygen acting as an oxidant. The oxidation state of Cytcwas used as an
indicator of the ambient redox potential. It was found that this
procedure caused the oxidation state of Cytc to vary from nearly fully
reduced to nearly fully oxidized over a period of several minutes and,
as data collection occurred every half second, this allowed several
hundred data points to be collected as the redox potential of Cytcwas
swept from low to high values.
Fig. 4A shows representative traces of oxidation changes in Cytc,
heme a, aH and aL from the chamber operating in oximetry mode
when ΔP was collapsed using a combination of oligomycin and FCCP.
Initially, oxygen concentration was saturating and was decreased to
anoxia at time zero resulting in the reduction of Cytc and heme a but
heme a remained in the aH form. Oligomycin inhibits the ATP synthase
and resulted in a slow conversion of aH to aL. Addition of FCCP
accelerated this conversion suggesting that heme awasmaintained in
the aH form by the presence of ΔΨ resulting from glycolytic ATP
reversing the synthase.
The cells were treated with 50 nM of rotenone at 5 min and then
the oxygen fraction in the tubing was increased from 0.00 to 0.05 at
6 min causing the oxygen concentration in the chamber to rise until
the oxygen consumption by the cells matched the oxygen delivery. It
was estimated that a tubing oxygen fraction of 0.05 would lead to a
cellular oxygen consumption that was ≈20% of the oxygen con-
sumption at saturating (baseline) oxygen tension. Baseline mito-
chondrial oxygen consumptionwas 28.9±4.1 μM/min, CytOx content
was 30.2±3.8 nM so that baseline CytOx turnover was≈16O2/s and
the turnover during the titration would have been less than 3.2O2/s.
The initiation of low rates of turnover resulted in a partial switch in
Fig. 2. (A) Oxygenated-anoxic difference attenuation spectra with (F+) and without (F−),
1 μM FCCP. (B) Residuals (data-model) of the ﬁtting model when the spectra in A are ﬁtted
with components bH, bL, c1, Cytc aL and a3. (C) Difference attenuation spectrumon addition of
FCCP with the component of bL that is ﬁtted into the spectrum. (D) Reconstructed speciﬁc
absorption spectra of aH compared to the literature spectra of heme a (assumed to be aL) and
a3 taken from [27].
Fig. 3. Traces of oxygen concentration (A) and oxidation changes of bH, bL, c1 (B), Cytc
(C) and CytOx (D), as the cells consume oxygen to anoxia and subsequent addition of
1 μM of FCCP (arrow). A downward deﬂection denotes reduction or increased
occupancy.
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the onset of low rates of proton pumping.
The combination of rotenone and oxygen caused the electron
transport chain to slowly oxidize and swept the redox potential of
Cytc from low to high values. Finally, the cells were treatedwith a high
concentration of rotenone (1 μM) and reoxygenated by increasing the
oxygen fraction in the tubing to 0.95 to fully oxidize the electron
transport chain.
Fig. 4B shows representative traces of oxidation changes in CytOx
and Cytc as a redox titration was performed when ΔP was maintained
by glycolytic ATP. Initially, oxygen concentration was saturating and
was decreased to anoxia at time zero by switching the oxygen in the
tubing to zero. Anoxia resulted in the reduction of Cytc and heme a but
heme a remained predominantly in the aH form. Cells were treated
with 50 nM rotenone at 2 min and the oxygen in the tubing was
increased to 0.05 at 3 min oxidizing the electron transport chain. A
second dose of 50 nM was given at 7 min to further oxidize the
electron transport chain and then the cells were treated with 1 μM
rotenone and reoxygenated to fully oxidize the electron transport
chain.
The redox titrations, with and without FCCP, were performed in
paired experiments on cells from the same culture and the paired
experiments were performed six times on cells from independent
cultures. The oxidation state of Cytc and heme a, and the fractional
occupation of aH and aL, were calculated assuming Cytc and heme a
were fully reduced during anoxia and fully oxidized at high oxygen
concentration after the high dose of rotenone. The redox potential of
Cytc was calculated using a Nernst relationship using a midpointpotential of 260 mV [18]. The data analysis was limited to the range of
180–340 mV, equivalent to an oxidation state of 5%–95% oxidized,
because outside this range small errors in Cytc oxidation state result in
large errors in Cytc redox potential.
The redox titrations with FCCP were ﬁtted with a 4-state redox
cooperativity model following Hendler and Westeroff [21] and the
data from Fig. 4A is shown with the ﬁt in Fig. 5A. The redox titrations
without FCCP could not be ﬁtted with a neoclassical model because
the lower transition, if present, was not sampled by the data. Instead,
heme a was ﬁtted as an n=1 Nernst function and the data from
Fig. 4B is shown with the ﬁt in Fig. 5B. Fig. 5C shows the relationship
between reduction of heme a and occupancy of aL and aH to Cytc redox
potential during the onset of anoxia from a representative experiment
along with a ﬁt with an n=1 Nernst function. The reduction state of
heme a ﬁtted a Nernst function at the later stages of the anoxia (low
Cytc redox potential) but was more oxidized than predicted at early
stages of the anoxia suggesting that the Em of heme a rose during the
onset of anoxia when ΔΨ would be expected to be decreasing. The
ﬁtting parameters and the shift in the Em of aH from the redox titration
with FCCP are shown in Table 1.
Fig. 4. Oxidation changes in heme a and Cytc during a redox titration in the presence (A) and absence (B) of oligomycin and FCCP. The cells were initially at a saturating oxygen
concentration and made anoxic at time zero. Additions to the chamber are marked with arrows and were O: oligomycin, F: 200 nM FCCP, RL: 50 nM rotenone, RH: 1 μM rotenone.
Changes in the oxygen fraction in the silicone tubing are marked with lines. A downward deﬂection denotes reduction or increased occupancy.
Fig. 5. Reduction of heme a (aT) and occupancy of aH and aL plotted against Cytc redox
potential. (A) During a redox titration in the presence of FCCP. (B) During a redox
titration in the absence of FCCP. (C) During the onset of anoxia. For A, the lines are a ﬁt
to the 4-parameter neoclassical model and B and C are a ﬁt with an n=1 Nernst
function to heme a.
784 N. Kim et al. / Biochimica et Biophysica Acta 1807 (2011) 779–7873.3. Stochastic models
Both model I andmodel II reproduced the time course of oxidation
changes in heme a and CuA from a kinetic study (see Fig. 6A and C,
respectively) but the third phase was slower in model II and heme a
showed slightly greater reduction in the second phase because the
electron is not transferred to heme a3. Model I pumped 0.90 protons
whereas model II pumped 0.70 protons.
Redox titrations for model I and II are shown in Fig. 6B and D,
respectively. CuA titrates as an n=1 Nernst function with an Em of
250 mV in both models (data not shown) as would be expected and
validates the algorithm for simulating a redox titration. The CuB center
also titrated as a simple n=1Nernst function in bothmodels but with
an effective Em of 580 mV rather than the 460 mV with which it acts
when it accepts an electron from heme a3 (see Fig. 1B). The increase in
the effective Em was caused by the pumped proton which was left in
an excited state after the electron left heme a but was not released
until after CuB was reduced. The result was that the lowest energy
statewith CuB reducedwas 120 mV below the energy level of the state
that accepted the electron from heme a3.
Heme a and heme a3 titrated with an Em of 360 mV for the ﬁrst
electron and with an Em of 480 mV for the second electron using the
parameters ofmodel I. This redoxcooperativity is contrary to theobserved
redox anti-cooperativity. The effective Emwas given by the sum of the Em
without a proton binding, the energy required to bind a proton and the
interaction energy. This amounts to −270mV+120mV−210 mV=
−360 mV for heme a and −130 mV+120mV−350 mV=−360 mV
for heme a3 for the ﬁrst electron. The proton was already bound for the
second electron so that it did not incur an energy penalty. The effective
midpoints were then −270 mV−210 mV=−480 mV and −130 mV
−350 mV=−480 mV for heme a and heme a3, respectively. Finally, this
model predicts that the pump proton will be bound whenever heme a is
reduced and so cannot reproduce the spectral changes observed in the
redox titrations.
In contrast, model II predicts redox anti-cooperativity between
heme a and heme a3. The pump site was protonatedwhen heme awas
reduced and the substrate site was protonated when heme a3 was
reduced. Ejection of the pump site proton was aided by the
electrostatic effect of the substrate proton but was not necessary to
Table 1
Midpoint potentials in millivolts calculated by ﬁtting the modiﬁed neoclassical model to the data from redox titrations with FCCP and by ﬁtting a Nernst function to heme a from
redox titrations without FCCP and from the onset of anoxia.
Experiment EmaH EmaL Ema3H Ema3L EmaH ΔEmaH EmaH ΔEmaH
With FCCP Without FCCP Anoxia
1 338.3 215.8 309.4 186.9 289.4 48.9 261.0 77.3
2 341.9 202.9 309.2 170.2 290.4 51.5 261.5 80.4
3 337.8 213.9 303.9 180.1 287.4 50.4 266.9 70.9
4 333.5 229.3 309.1 204.8 284.6 48.9 259.9 73.7
5 341.2 214.6 301.4 174.8 288.2 52.9 258.4 82.7
6 332.6 232.3 309.3 209.1 292.7 39.9 257.8 74.8
Mean±SD 337.6±3.5 218.2±9.9 307.1±3.2 187.7±14.6 288.8±2.5 48.8±4.2 260.9±3.0 76.6±4.1
ΔEmaH is the shift in midpoint potential of aH from redox titration with FCCP. EmaHand EmaL are the midpoint potentials of aH, aL. Ema3H and Ema3L are the midpoint potentials of heme a3 when it
has a high and low potential, respectively, and ΔEmaHis the change in midpoint potential from the redox titration with FCCP.
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reduction. However, the strong anti-cooperativity between the two
proton sites forbids uptake of a second proton when the second
electron arrives so that heme a and heme a3 act with an effective Em of
270 and 130 mV, respectively. As heme a has the higher Em, only the
state in which both hemes are reduced and the proton resides on the
heme a3 binding center was sampled during the redox titration. The
end result was that heme a and a3 appear to titrate with an effective
Em of 360 and 270 mV for the ﬁrst and second electron, respectively,
when this 16-state system (2 redox centers and 2 proton sites) is
analyzed with a simple 4-state redox cooperativity model. Finally, the
fractional occupation of aH and aL correspond precisely to the
occupancy of heme awhen it acts with a high or low Em, respectively.
Overall, the results of model II showed good qualitative agreement to
the data reproducing both redox anti-cooperativity and the observed
spectral changes.Fig. 6. Results of the stochastic simulations for model I (A and B) and model II (C and D). A
systemwhen CuA is reduced, the other redox centers are oxidized and the proton sites are em
and the lines are from a ﬁt using a 4-state redox cooperativity model.4. Discussion
Spectral changes have been observed in the α-band of CytOx
during redox titrations [13,14,30], after CO photolysis in the mixed
valence enzyme [31], after photo injection of an electron in the CuA
site [24] and stopped-ﬂow mixing with reduced Cytc [32] but there
have been few attempts to assign these spectral changes to speciﬁc
states of the enzyme. The Wilson et al. interpretation [13,14], but see
also [30], assigns the 602 and 608 nm spectral features to heme a and
heme a3, respectively. If these spectral components are used for
spectral ﬁtting then the 602 and 608 nm components follow aT and aL,
respectively, due to the linear nature of the ﬁtting algorithm.
However, this interpretation has been rejected [15] on the grounds
that redox titrations in which heme a3 is held reduced by the presence
of carbon monoxide, show a single spectral feature with near equal
magnitude to the fully reduced-oxidized difference spectrum [12].and C temporal evolution of the reduction state of CuA and heme a, and charge transfer
pty at t=0. B and D simulated redox titrations. The data points are from the simulation
786 N. Kim et al. / Biochimica et Biophysica Acta 1807 (2011) 779–787Furthermore, magnetic circular dichroism redox titrations of both
heme a and heme a3 show they titrate together [18]. More
sophisticated analysis has been performed with single value decom-
position algorithms [33,34] but a fundamental assumption of that
analysis was that the spectral components titrate with a Nernst
functional form whereas aH clearly does not titrate in that way. It has
been previously proposed that the absorption peak of the oxidized
minus half-reduced enzyme is 603–604 nm whereas the peak of the
oxidized minus fully reduced enzyme is at 605 nm [15,35], consistent
with the spectra and interpretation presented here. However, this is
the ﬁrst time that the spectral features of CytOx in the α-band region
have been separated, quantiﬁed and interpreted in terms of the
effective Em of heme a resulting from protonation events.
Within the framework of the neoclassical model, the observation
that aL and aH titrate as the low and high potential components of
heme a would suggest that the spectrum of heme a depends on the
oxidation state of heme a3. This is unlikely to be the case because the
difference spectrum of heme a has a peak at 605 nm when either a3 is
held reduced with carbon monoxide [15] or held oxidized with
cyanide [27,36]. In addition, time resolved studies show that heme a
has an absorption peak at 605 nm when an electron is initially
injected into the oxidized enzyme [24,32], a time when the
neoclassical model would predict that heme a has a high potential
and hence an absorption at 602 nm.
In the absence of proton binding, the effective Em of heme a with
respect to cytochrome c should decrease with increasing ΔΨ by a
factor equal to the dielectric depth of heme a because the electron has
to move against the electric ﬁeld. Quantiﬁcation of the mitochondrial
membrane potential from living cells is error prone but previous
studies have estimated a baseline value of 150 mV [37]. This would
seem to be compatible with a shift of 48.6 mV in the Em of aH between
redox titrations in the presence and absence of oligomycin and FCCP
assuming a dielectric depth of 0.34. However, ΔΨ was unlikely to be
zero in the presence of oligomycin at this relatively low concentration
of FCCP when the electron transport chain was still pumping protons
at 20% of normal values. Furthermore, ΔΨ should be considerably
lower than 150 mV when it is maintained by glycolytic ATP reversing
the ATP synthase rather than under normal turnover conditions when
ΔΨ drives the ATP synthase forward. Finally, the shift in the Em of aH of
greater than 76 mV on the onset of anoxia when ΔΨ is expected to be
close to 150 mV is incompatible with a dielectric depth of 0.34.
Therefore, formation of aHmust involve a greater movement of charge
against ΔΨ than can be accounted for by the electron moving from
Cytc to heme a. The most obvious candidate for this movement of
charge is the uptake of a proton. The binding of the proton at the
pump site could be directly responsible for the change in Em and
spectrum of heme a. Alternatively, proton binding could trigger a
conformational change that alters the spectrum of heme a or a
conformational change could alter the Em and spectrum of heme a and
the pKa of the pump site. Conformational changes of the arginines
above the propionates of heme a (R481 and R482, R. sphaeroides
numbering) have been proposed [38] and point mutations of R481
generate shifts in the spectra of heme a of similar magnitude seen
here [39].
The goal of the stochastic simulations is to use the kinetic
parameters of the ﬁrst electron reduction of CytOx (O to E transition)
to predict the reduction by the second, third and fourth electron as
occurs in a redox titration. It is already known that the kinetic
parameters of the additional electrons must be different from the ﬁrst
electron and this approach is able to identify those differences. An
obvious failure of model I is that it does not include a substrate proton
on the second electron reduction of the binuclear center (E to R
transition) and there is no obvious way to include protonation
interactions as heme a3 would already have a high midpoint potential
due to the interaction with the pump proton. The model accurately
predicts the uptake of three protons on the 4 electron reduction of theoxidized enzyme but it predicts two pump protons and one substrate
proton rather than one pump proton and two substrate protons.
Finally, heme a and a3 titrate with redox cooperativity rather than the
anti-cooperativity as is observed.
Model II attempts to implement the proton pumping scheme of
West et al. [40] in which the pumped proton is taken up faster than
the substrate proton to neutralize the negative charge of the electron
at heme a. The subsequent uptake of the substrate proton, which
binds more tightly to the electron at heme a3, then ejects the pump
proton through electrostatic repulsion. In this model, the midpoint
potential of heme a is dependent on the pump proton, having an Em of
270 and 360 mV in the absence and presence of the proton, whereas
the Em of heme a3 is dependent on the substrate proton, having an Em
of 130 and 360 mV in the absence and presence of the proton (see
Fig. 1C). Redox anti-cooperativity occurs because the pump and the
substrate proton binding sites cannot be occupied simultaneously due
to the electrostatic repulsion. The lower Em for the second electron
observed in redox titrations (218 mV) compared to the simulations
(270 mV) could be the result of a residual electrostatic interaction
between the electrons on heme a and a3 but it should bemuch smaller
than would be predicted from a simple electrostatic calculation
considering the separation of the hemes because it would be
counteracted by the charge on the substrate proton. Model II predicts
that the pump proton binding site is empty in the fully reduced
enzyme and so explains why the 602 nm spectrum is only observed at
intermediate levels of reduction. It also means that any conforma-
tional change that accompanies the uptake of the pump proton and
alteration in the Em of heme a would not be observed in the crystal
structure of the fully oxidized or fully reduced enzyme. Likewise,
heme a titrates with a peak at 605 nm in the CO-bound and CN-bound
enzyme indicating that the pump site is empty and any conforma-
tional change would not be apparent in the CO-bound crystal
structure.
This model could also account for the failure to reduce heme a3
under anoxic conditions when ΔP is maintained by glycolytic ATP.
Reduction of heme a3 requires uptake of the substrate proton and
ejection of the pump proton against ΔP and, for a given ΔP, this will
decrease the effective Em of heme a3 substantially more than it
decreases the effective Em of heme a. Furthermore, the residual ΔΨ
during the titration with FCCP could account for the apparent
difference in midpoint potentials of the two hemes. Taking these
effects into account, the data from the redox titration in the presence
of FCCP are in good agreement with those of the isolated enzyme.
These effects could be conﬁrmed by performing titrations at
intermediate values of ΔP. Furthermore, quantifying the shift in
midpoint potentials of heme a and heme a3 with ΔΨ should provide
further information with regard to the location of the pump proton
site and pumping mechanism.
5. Conclusion
The data and stochastic simulations presented here are consistent
with a model in which uptake of the pumped proton alters the
midpoint potential of heme a, blueshifts its α-band absorption peak
from 605 to 602 nm and, in combination with the substrate proton
altering the Em of heme a3, gives rise to much of the apparent redox
anti-cooperativity observed in redox titrations. Multi-wavelength
decomposition of α-band attenuation spectra into the aH and aL
components should be invaluable in interpreting a variety of optical
studies as it should provide additional information to track the proton
uptake and protonation status of the pump site.
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